China's domestic AI stack achieves "good enough" inference parity through scaled lower-grade accelerators, software co-optimization, and localized DRAM production; US export-control tightening now mak

Following January 2026 US export-control revisions that shifted advanced AI chip sales to case-by-case licensing, Chinese authorities blocked imports and discouraged adoption of US technology, creating an effective supply-unpredictability barrier. China is now executing a systems-level workaround: Huawei's Atlas 900 A3 SuperPoD scales 384 Ascend 910C chips (each delivering approximately 40% of H100 inference performance) to exceed Nvidia's GB200 throughput at the cost of worse power efficiency; the open-source CANN toolchain is achieving early ecosystem synergies with native model deployment (DeepSeek); and CXMT's DRAM production has scaled to 8% market share in Q3 2025 and is attempting mass production of HBM2 and HBM3 despite constrained lithographic access. The shift is not toward outright chip parity but toward a domestically controlled, supply-reliable stack optimized for inference and fine-tuning. For financial institutions, this suggests US export controls are forcing accelerated indigenization rather than curbing it, with direct implications for Nvidia's addressable market size, supply-chain diversification costs for US hyperscalers, and geopolitical volatility in AI-semiconductor valuations.